News from pfenex inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 13, 2014, 16:05 ET
Pfenex logo.

Pfenex Reports Third Quarter 2014 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

Nov 06, 2014, 08:30 ET
Pfenex logo

Pfenex To Report Third Quarter 2014 Results and Provide Business Update on Thursday, November 13, 2014

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

Oct 09, 2014, 17:00 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex and PATH Partner on Vaccines

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value biosimilar therapeutics and...

Oct 02, 2014, 08:00 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex Added to Both Russell Microcap® Index and Russell Global Indexes

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced...

Oct 01, 2014, 16:05 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex to Present at 13th Annual BIO Investor Forum

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins...

Sep 25, 2014, 08:00 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex Adds New Board Member

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture...

Sep 19, 2014, 08:30 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex to Present at Upcoming Industry Conference on September 26

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins...

Aug 29, 2014, 16:05 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex Reports Second Quarter 2014 Results and Provides Business Update

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture...

Jul 29, 2014, 16:10 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex Announces Closing of Initial Public Offering

Pfenex Inc. (NYSE MKT: PFNX) today announced that it has closed its previously announced initial public offering of 8,333,333 shares of its common...

Jul 24, 2014, 00:25 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex Inc. Announces Pricing Of Initial Public Offering

Pfenex Inc. (NYSE MKT: PFNX) today announced the pricing of its initial public offering of 8,333,333 shares of its common stock at a price to the...

Jun 06, 2014, 08:30 ET

Pfenex Files Registration Statement With SEC For An Initial Public Offering

 Pfenex Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial...

Dec 17, 2013, 09:05 ET

Pfenex Awarded Contract For Development Of Next Generation rPA-Based Anthrax Vaccine

Pfenex Inc. today announced that Leidos Holdings, Inc. (NYSE: LDOS) (formerly SAIC) has awarded Pfenex a subcontract in support of the development...

Nov 05, 2013, 09:00 ET

Pfenex Inc. Awards Paragon Bioservices a Contract for cGMP Manufacturing of its Recombinant Protective Antigen (rPA), for Phase 1 Clinical Trial of its Anthrax Vaccine

Pfenex Inc. today announced that it has awarded Paragon Bioservices a contract for the current Good Manufacturing Practice (cGMP) manufacturing of...

Oct 29, 2013, 09:00 ET

Pfenex Inc. awarded a subcontract by Leidos to develop a scalable cGMP production process for a second key malaria antigen

 Pfenex Inc. today announced that Leidos Holdings, Inc. (NYSE: LDOS) (formerly SAIC) has awarded Pfenex a subcontract to develop a robust,...

Oct 01, 2013, 09:00 ET
Apr 30, 2013, 06:00 ET

Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine

 Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant...

Apr 16, 2013, 06:15 ET

Pfenex Inc. and Agila Biotech Private Limited Announce Joint Venture to Develop Biosimilar Products for the Global Market

Pfenex Inc. and Agila Biotech Private Limited, a subsidiary of Strides Arcolab Limited today announced that they have entered into a joint venture...

Jan 16, 2013, 06:00 ET

Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Capacity Expansion For cGMP CRM197 Production

Pfenex Inc.'s Reagent Proteins division announced today that its CRM197 manufacturing partner, Serum Institute of India Ltd., has...

Oct 24, 2012, 13:26 ET
www.altheatech.com.  (PRNewsFoto/Pfenex Inc.)

Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen

 Pfenex Inc. today announced that it has awarded Althea Technologies a contract for the current Good Manufacturing Practice (cGMP)...

Oct 17, 2012, 09:00 ET

Pfenex Inc. Awarded Contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA)-based Anthrax Vaccine

 Pfenex Inc. today announced that the National Institute of Allergy and Infectious Diseases (NIAID) under its Broad Agency Announcement...